SCHEMBL9491702

SCHEMBL9491702

CN(C)CCCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29165313 0.97 ALDH1A1 (0.69)
SCHEMBL896593 0.90
Hydrochloric Acid SCHEMBL19922527 0.87
Iodide SCHEMBL296056 0.87
SCHEMBL21216 0.82 ALDH1A1 (0.91)
Hydrochloric Acid SCHEMBL10934116 0.78 ALDH1A1 (0.83)
SCHEMBL1729138 0.78 ALDH1A1 (1.00)
SCHEMBL7942101 0.78 ALDH1A1 (1.00)
SCHEMBL35856 0.78 ALDH1A1 (1.00)
SCHEMBL235238 0.78 ALDH1A1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11785845-B2 Composition FUJIFILM CORPORATION (JP) 2023-10-10 US disclosed
WO-2023116761-A1 PYRIMIDINE HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE 英矽智能科技知识产权有限公司 2023-06-29 WO disclosed
WO-2023119098-A1 PROTEIN KINASE C THETA INHIBITORS Galderma Holding SA (CH) 2023-06-29 WO disclosed
EP-3405477-B1 INHIBITORS OF TRANSGLUTAMINASES ZEDIRA GMBH (DE) 2023-06-07 EP disclosed
US-11566022-B2 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof NOVARTIS AG (CH) 2023-01-31 US disclosed
WO-2023275337-A1 INHIBITORS OF TRANSGLUTAMINASES ZEDIRA GMBH (DE) 2023-01-05 WO disclosed
WO-2023275333-A1 INHIBITORS OF TRANSGLUTAMINASES ZEDIRA GMBH (DE) 2023-01-05 WO disclosed
US-20220389016-A1 COMPOUND AND METHOD FOR PRODUCING COMPOUND FUJIFILM CORPORATION (JP) 2022-12-08 US disclosed
US-20220045283-A1 COMPOSITION FUJIFILM CORPORATION (JP) 2022-02-10 US disclosed
EP-3568391-B1 BENZENE DISULFONAMIDE FOR THE TREATMENT OF CANCER MAX PLANCK GESELLSCHAFT (DE) 2020-11-11 EP disclosed
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed
EP-3357904-A1 CHIRAL DIACHYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX Intrexon Corporation (US) 2018-08-08 EP disclosed
EP-3351544-A1 BENZENE DISULFONAMIDE FOR THE TREATMENT OF CANCER Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2018-07-25 EP disclosed
WO-2018130625-A1 BENZENE DISULFONAMIDE FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2018-07-19 WO disclosed
WO-2018122419-A1 INHIBITORS OF TRANSGLUTAMINASES ZEDIRA GMBH (DE) 2018-07-05 WO disclosed
EP-3342779-A1 INHIBITORS OF TRANSGLUTAMINASES Zedira GmbH (DE) 2018-07-04 EP disclosed
WO-2017041701-A1 NITRIC OXIDE-RELEASING PRODRUG MOLECULE 浙江华海药业股份有限公司 2017-03-16 WO disclosed
WO-2016203112-A1 SPIRO[CYCLOBUTANE-1,3'-INDOLIN]-2'-ONE DERIVATIVES AS BROMODOMAIN INHIBITORS ORION CORPORATION (FI) 2016-12-22 WO disclosed
US-5256651-A Thickeners for subterranean formation fracturing fluids RHONE-POULENC, INC. (US) 1993-10-26 US disclosed
EP-0496584-A2 Hydrophilic-Hydrophobic derivatives of polygalactomannans containing tertiary amine functionality STEIN, HALL &amp; CO., INC. (US) 1992-07-29 EP disclosed